Literature DB >> 14693854

Malignant transformation of a recurrent vestibular schwannoma.

J S Wilkinson, H Reid, G R Armstrong.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14693854      PMCID： PMC1770165          DOI： 10.1136/jcp.57.1.109

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  Recurrence of acoustic neurilemoma as a malignant spindle-cell neoplasm. Case report.

Authors:  C A McLean; J D Laidlaw; D S Brownbill; M F Gonzales
Journal:  J Neurosurg       Date:  1990-12       Impact factor: 5.115

2.  Malignant transformation of a benign encapsulated neurilemoma.

Authors:  P H Carstens; G R Schrodt
Journal:  Am J Clin Pathol       Date:  1969-01       Impact factor: 2.493

3.  Malignant nerve sheath tumor of acoustic nerve.

Authors:  M Kudo; M Matsumoto; H Terao
Journal:  Arch Pathol Lab Med       Date:  1983-06       Impact factor: 5.534

4.  Postirradiation neurofibrosarcoma.

Authors:  B S Ducatman; B W Scheithauer
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

5.  Malignant epithelioid schwannoma arising in a benign schwannoma. A case report.

Authors:  S A Yousem; T V Colby; H Urich
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860
  5 in total
  15 in total

1.  On "malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery" (skull base 2010;20:381-388).

Authors:  Sami Tanbouzi Husseini; Enrico Piccirillo; Mario Sanna
Journal:  Skull Base       Date:  2011-03

Review 2.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

3.  Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery.

Authors:  Andreas K Demetriades; Nicholas Saunders; Peter Rose; Cyril Fisher; Jeremy Rowe; Robert Tranter; Carl Hardwidge
Journal:  Skull Base       Date:  2010-09

4.  Surgical management of vestibular schwannomas after failed radiation treatment.

Authors:  Yoichi Nonaka; Takanori Fukushima; Kentaro Watanabe; Allan H Friedman; Calhoun D Cunningham; Ali R Zomorodi
Journal:  Neurosurg Rev       Date:  2016-01-19       Impact factor: 3.042

5.  A case of high-grade undifferentiated sarcoma after surgical resection and stereotactic radiosurgery of a vestibular schwannoma.

Authors:  Tong Yang; Jason Rockhill; Donald E Born; Laligam N Sekhar
Journal:  Skull Base       Date:  2010-05

6.  Delayed microsurgery for vestibular schwannoma after gamma knife radiosurgery.

Authors:  Cheng-Chia Lee; Yu-Shu Yen; David Hung-Chi Pan; Wen-Yuh Chung; Hsin-Mei Wu; Wan-Yuo Guo; Ming-Te Chen; Kang-Du Liu; Yang-Hsin Shih
Journal:  J Neurooncol       Date:  2010-04-20       Impact factor: 4.130

7.  Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature.

Authors:  Anandh Balasubramaniam; Patrick Shannon; Mojgan Hodaie; Normand Laperriere; Howard Michaels; Abhijit Guha
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

8.  The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Authors:  J Jason Clark; Matthew Provenzano; Henry R Diggelmann; Ningyong Xu; Skylar S Hansen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

9.  Outcomes of stereotactic radiosurgery in young adults with vestibular schwannomas.

Authors:  Mariko Kawashima; Hirotaka Hasegawa; Masahiro Shin; Yuki Shinya; Atsuto Katano; Nobuhito Saito
Journal:  J Neurooncol       Date:  2021-07-09       Impact factor: 4.130

10.  Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors.

Authors:  Bénédicte L'heureux-Lebeau; Issam Saliba
Journal:  Onco Targets Ther       Date:  2013-04-26       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.